@article{dc284f591f5a49c6baf90061bb799466,
title = "Hypothesis: Amelioration of obesity-induced cognitive dysfunction via a lorcaserin–betahistine combination treatment",
keywords = "betahistine, cognition, combination treatment, lorcaserin, obesity, Betahistine/pharmacology, Dopamine, Rats, Rats, Sprague-Dawley, Animals, Benzazepines, Cognitive Dysfunction/drug therapy, Obesity/complications",
author = "\{dela Pe{\~n}a\}, \{Ike C.\} and Figueroa, \{Johnny D.\} and Shi, \{Wei Xing\}",
note = "{\textcopyright} 2022 The Authors. Pharmacology Research \& Perspectives published by John Wiley \& Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.",
year = "2022",
month = jun,
doi = "10.1002/prp2.947",
language = "English",
volume = "10",
pages = "e00947",
journal = "Pharmacology Research and Perspectives",
issn = "2052-1707",
number = "3",
}